Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Lucid Diagnostics (LUCD) Revenue (2021 - 2025)

Lucid Diagnostics (LUCD) has disclosed Revenue for 5 consecutive years, with $1.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Revenue rose 3.16% year-over-year to $1.2 million, compared with a TTM value of $4.4 million through Sep 2025, up 3.87%, and an annual FY2024 reading of $4.3 million, up 77.1% over the prior year.
  • Revenue was $1.2 million for Q3 2025 at Lucid Diagnostics, up from $1.2 million in the prior quarter.
  • Across five years, Revenue topped out at $1.2 million in Q3 2025 and bottomed at -$147000.0 in Q2 2021.
  • Average Revenue over 5 years is $647375.0, with a median of $805500.0 recorded in 2023.
  • The sharpest move saw Revenue crashed 62.0% in 2022, then soared 930.26% in 2023.
  • Year by year, Revenue stood at $200000.0 in 2021, then tumbled by 44.0% to $112000.0 in 2022, then skyrocketed by 828.57% to $1.0 million in 2023, then increased by 10.67% to $1.2 million in 2024, then increased by 5.04% to $1.2 million in 2025.
  • Business Quant data shows Revenue for LUCD at $1.2 million in Q3 2025, $1.2 million in Q2 2025, and $828000.0 in Q1 2025.